EP3960735

QUINAZOLINE DERIVATIVES USED TO TREAT HIV

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    23.12.2015
  • EP published:
    13.9.2023
  • EP application number:
    21187414.4
  • Max expiry date:
    22.12.2035
  • Title in English:
    QUINAZOLINE DERIVATIVES USED TO TREAT HIV
  • Language of the patent:
    English

Timeline

Today
23.12.2015EP application
13.9.2023EP Publication

Owner

  • Name:
    Gilead Sciences, Inc.
  • Address:
    333 Lakeside Drive, Foster City, CA 94404, US
  • Name:
    Institute of Organic Chemistry and Biochemistry AS CR, V.V.I.
  • Address:
    Flemingovo nam. 2, 16610 Praha 6, CZ

Inventor

  • Name:
    JANSA, Petr
  • Address:
    Foster City, US
  • Name:
    SIMON, Petr
  • Address:
    Praha, CZ
  • Name:
    LANSDON, Eric
  • Address:
    Foster City, US
  • Name:
    HU, Yunfeng Eric
  • Address:
    Foster City, US
  • Name:
    BASZCZYNSKI, Ondrej
  • Address:
    Praha, CZ
  • Name:
    DEJMEK, Milan
  • Address:
    Praha, CZ
  • Name:
    MACKMAN, Richard L.
  • Address:
    Foster City, US

Priority

  • Number:
    201462096748 P
  • Date:
    24.12.2014
  • Country:
    US

Classification

  • Categories:
    C07D 239/94, C07D 401/12, A61K 31/517, A61P 31/18

Upload documents